SEC Form D private-offering filing

SwitchPoint Bio Holding, Inc.

Name: SwitchPoint Bio Holding, Inc. - new SEC Form D private-offering filing, Wilmington, DE
Published: 2026-03-10

A new SEC Form D private-offering notice from Wilmington, DE, a $5,270,000 filer-stated offering target in Biotech. The source filing is one click away.

SwitchPoint Bio Holding, Inc. site↗ Verified via SEC Form D

Immune biology company that analyzes blood samples to characterize immune cell composition and function for drug discovery and clinical trial design

Filed 2026-03-10Filed to raise $5,270,000First money in 2026-03-09Raised so far $5,270,000HQ (as filed) Wilmington, DESector Biotech ✓Stage (inferred) EarlyCall status Call-ready

Source linked the Form D on EDGAR↗Website verified switchpointbio.com↗Named in the filing 3 executives & directors

Open this row on the live feed →More new filings in Delaware →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.